These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4598861)

  • 21. [Comparative susceptibility testing to sulfamethoxazole and trimethoprim by agar diffusion test on different media (author's transl)].
    Freiesleben H; Marre R
    Immun Infekt; 1978 Dec; 6(6):223-5. PubMed ID: 365716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to trimethoprim in 1978-79 compared with 1973-75.
    Hamilton-Miller JM; Gooding A; Brumfitt W
    J Clin Pathol; 1981 Apr; 34(4):439-42. PubMed ID: 7016927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
    Wong CK; Harding GK; Ronald AR; Hoban S
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Isolation of thymidine-dependent strains. Microbiologic considerations and personal observations].
    Grigis A; Tosi CP; Raglio A; Goglio A
    Quad Sclavo Diagn; 1986 Jun; 22(2):215-22. PubMed ID: 3547456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the antibacterial activity of sulphonamide-trimethoprim combinations.
    Fourie ED; van Straten AM; Maritz HC; van Rensburg AJ
    S Afr Med J; 1979 Mar; 55(14):544-7. PubMed ID: 377523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sensitization test against trimethoprim-sulfamethoxazole].
    Tauchnitz C; Tattermann G
    Z Gesamte Inn Med; 1972 May; 27(9):390-5. PubMed ID: 4626641
    [No Abstract]   [Full Text] [Related]  

  • 27. Sulphonamide-induced 'thymineless death' in Escherichia coli.
    Then R; Angehrn P
    J Gen Microbiol; 1973 Jun; 76(2):255-63. PubMed ID: 4579126
    [No Abstract]   [Full Text] [Related]  

  • 28. Trimethoprim-sulfamethoxazole therapy of neonatal Proteus mirabilis meningitis unresponsive to cefotaxime.
    Velvis H; Carrasco N; Hetherington S
    Pediatr Infect Dis; 1986; 5(5):591-3. PubMed ID: 3532051
    [No Abstract]   [Full Text] [Related]  

  • 29. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K; Korner B
    Chemotherapy; 1974; 20(2):97-101. PubMed ID: 4210895
    [No Abstract]   [Full Text] [Related]  

  • 30. Combinations of antimicrobial agents. III. The in vitro sensitivity of 12 strains of Pseudomonas aeruginosa and 12 strains of proteus species ot sulphamethoxazole + trimethoprim (co-trimoxazole), polymyxins and combinations of co-trimoxazole and polymyxins.
    Kuipers JS
    Arch Chir Neerl; 1976; 28(2):91-9. PubMed ID: 823875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Synergism of trimethoprim and sulfamethoxazole action on microorganisms isolated from persons with urinary tract infections].
    Ganczarski A; Augustyniak B; Kloczkowski K; Prelich A; Stapor K
    Med Dosw Mikrobiol; 1972; 24(4):307-14. PubMed ID: 4632270
    [No Abstract]   [Full Text] [Related]  

  • 32. Co-trimoxazole resistance.
    Lancet; 1986 Feb; 1(8477):364. PubMed ID: 2868303
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on the microbial resistance to the drug combination sulfamethoxazole trimethroprim with special reference to enterococci].
    Gärtner H; Dieterich F
    Arzneimittelforschung; 1973 Apr; 23(4):597-600. PubMed ID: 4197072
    [No Abstract]   [Full Text] [Related]  

  • 34. The combination of trimethoprim and sulfamethoxazole in the treatment of urinary tract infection.
    Crichton EP; McDonnell CE
    Can Med Assoc J; 1972 Aug; 107(4):292-5. PubMed ID: 4626767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Resistance patterns of certain Enterobacteriaceae in hospital and outpatients, with particular reference to trimethoprim-sulfamethoxazole (author's transl)].
    Freitag V
    MMW Munch Med Wochenschr; 1976 Feb; 118(9):275-8. PubMed ID: 817195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin.
    Bailey RR; Peddie BA
    N Z Med J; 1988 Apr; 101(844):216-7. PubMed ID: 3283613
    [No Abstract]   [Full Text] [Related]  

  • 37. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
    Murray BE; Rensimer ER; DuPont HL
    N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A reappraisal of the antibacterial action of cotrimoxazole in vitro.
    Lewis EL; Anderson JD; Lacey RW
    J Clin Pathol; 1974 Feb; 27(2):87-91. PubMed ID: 4596417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance of urinary tract isolates of Escherichia coli to cotrimoxazole, sulphonamide, trimethoprim and ampicillin: an 11-year survey.
    Peddie BA; Bailey RR; Wells JE
    N Z Med J; 1987 Jun; 100(825):341-2. PubMed ID: 3330584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Trimethoprim-sulphamethoxazole--a study on resistance patterns in Escherichia coli].
    Madsen ST
    Tidsskr Nor Laegeforen; 1973 Nov; 93(30):2244-5. PubMed ID: 4588011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.